Chromium Chromium is a trace mineral included in Golo Release
What happens if I miss a dose of my GLP-1 injection
The next phase of the GLP-1 race will be won by companies that think beyond the molecule
Our commitment to our patients: to restore the feeling of exceptional customer service and the trusted care of an old-school pharmacy, where your health and wellness truly come first
Study Finds Diabetes Medication Reduces Risk Of Death And Heart Disease In People With Arthritis August 12, 2024 (Vancouver) A study conducted by Arthritis Research Canada has revealed that certain diabetes medications, specifically glucagon-like peptide-1 receptor agonists (GLP-1-RAs) like semaglutide (Ozempic), reduced the risk of death and heart attacks in people with immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis, psoriasis, and lupus, who also have type 2 diabetes
Long-term outcomes in nephropathic cystinosis: a review